Abstract
The pharmacoinvasive strategy is a modern approach to ST-elevation myocardial infarction (STEMI). According to it, the healthcare provider uses a fibrinolytic drug immediately after the diagnose of STEMI, with a routine transference of the patient (if clinically stable) to a tertiary hospital, between 3 and 24 hours after the administration of the medication, in order for him/her to be su…